These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33882749)
1. In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors. Wilson BAP; Voeller D; Smith EA; Wamiru A; Goncharova EI; Liu G; Lipkowitz S; O'Keefe BR SLAS Discov; 2021 Aug; 26(7):870-884. PubMed ID: 33882749 [TBL] [Abstract][Full Text] [Related]
2. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. De Cesare V; Johnson C; Barlow V; Hastie J; Knebel A; Trost M Cell Chem Biol; 2018 Sep; 25(9):1117-1127.e4. PubMed ID: 30017913 [TBL] [Abstract][Full Text] [Related]
3. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases. Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574 [TBL] [Abstract][Full Text] [Related]
4. Targeted modulation of E3 ligases using engineered ubiquitin variants. LeBlanc N; Mallette E; Zhang W FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007 [TBL] [Abstract][Full Text] [Related]
5. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136 [TBL] [Abstract][Full Text] [Related]
7. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination. Sévère N; Miraoui H; Marie PJ J Biol Chem; 2011 Jul; 286(27):24443-50. PubMed ID: 21596750 [TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia. Liu L; Xiang Y; Shao L; Yuan C; Song X; Sun M; Liu Y; Zhang X; Du S; Hou M; Peng J; Shi Y J Thromb Haemost; 2024 Apr; 22(4):1202-1214. PubMed ID: 38184203 [TBL] [Abstract][Full Text] [Related]
9. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. Dogan T; Gnad F; Chan J; Phu L; Young A; Chen MJ; Doll S; Stokes MP; Belvin M; Friedman LS; Kirkpatrick DS; Hoeflich KP; Hatzivassiliou G J Biol Chem; 2017 Sep; 292(35):14311-14324. PubMed ID: 28655764 [TBL] [Abstract][Full Text] [Related]
10. A Generic Platform for Cellular Screening Against Ubiquitin Ligases. Maculins T; Carter N; Dorval T; Hudson K; Nissink JW; Hay RT; Alwan H Sci Rep; 2016 Jan; 6():18940. PubMed ID: 26743172 [TBL] [Abstract][Full Text] [Related]
11. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers. Masumoto K; Kitagawa M Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119 [TBL] [Abstract][Full Text] [Related]
12. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions. Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential. Wu K; Huynh KQ; Lu I; Moustakim M; Miao H; Yu C; Haeusgen MJ; Hopkins BD; Huang L; Zheng N; Sanchez R; DeVita RJ; Pan ZQ Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33602808 [TBL] [Abstract][Full Text] [Related]
14. Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay. Herman AG; Hayano M; Poyurovsky MV; Shimada K; Skouta R; Prives C; Stockwell BR Cancer Discov; 2011 Sep; 1(4):312-25. PubMed ID: 22586610 [TBL] [Abstract][Full Text] [Related]
15. TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b. Chirino LM; Kumar S; Okumura M; Sterner DE; Mattern M; Butt TR; Kambayashi T Eur J Immunol; 2020 Jan; 50(1):48-55. PubMed ID: 31531847 [TBL] [Abstract][Full Text] [Related]